Effect of F2695 on Brain Activity Measured by Functional Magnetic Resonance Imaging

NCT02266966 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Subject

Interventions

DRUG: F2695
DRUG: Placebo

Sponsor

Pierre Fabre Medicament